The National Eye Institute awarded Mingquan Lin, PhD, a five-year $3.7 million NIH grant to develop AI for primary open-angle glaucoma prognosis. The work, led through the University of Minnesota Medical School’s Division of Computational Health Sciences, targets earlier identification of patients at risk of progression. For companies and health systems working on ophthalmic AI, the grant underscores NIH support for clinically deployable prediction tools rather than diagnosis-only models. It also reinforces demand for longitudinal performance evaluation using real-world imaging and clinical data. The funding provides a concrete pathway for moving AI risk scores from research prototypes toward prospective validation.